Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,564 | -87,382 | -91,123 | -98,921 | -52,006 |
| Depreciation Amortization | 6,201 | 3,967 | 3,237 | 2,407 | 11,090 |
| Accounts payable and accrued liabilities | 63 | -540 | 1,129 | 1,037 | -14,671 |
| Other Working Capital | -440 | -247 | 2,040 | 4,250 | -24,556 |
| Other Operating Activity | 69,898 | 70,819 | 75,244 | 90,095 | 25,615 |
| Operating Cash Flow | $-15,842 | $-13,383 | $-9,473 | $-1,132 | $-54,528 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54,534 | -50,081 | -55,064 | -33,920 | N/A |
| PPE Investments | -61 | -48 | N/A | N/A | -11 |
| Investing Cash Flow | $-54,595 | $-50,129 | $-55,064 | $-33,920 | $-11 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 89,643 | N/A | N/A | 744 |
| Debt Repayment | -6,516 | -4,887 | -3,258 | -1,629 | -6,233 |
| Common Stock Issued | 89,643 | N/A | 89,648 | 88,611 | 24,926 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 45,038 |
| Financing Cash Flow | $83,127 | $84,756 | $86,390 | $86,982 | $64,475 |
| Exchange Rate Effect | 4 | -14 | -2 | -6 | -11 |
| Beginning Cash Position | 14,816 | 14,816 | 14,816 | 14,816 | 4,891 |
| End Cash Position | 27,510 | 36,046 | 36,667 | 66,740 | 14,816 |
| Net Cash Flow | $12,694 | $21,230 | $21,851 | $51,924 | $9,925 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,842 | -13,383 | -9,473 | -1,132 | -54,528 |
| Capital Expenditure | -61 | -48 | N/A | N/A | -11 |
| Free Cash Flow | -15,903 | -13,431 | -9,473 | -1,132 | -54,539 |